MUC1 and colorectal cancer pathophysiology considerations

World Journal of Gastroenterology

Volumn 14, Issue 14, 2008, Pages 2139-2141

  Niv, Yaron ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

Carcinogenesis; Colorectal cancer; Gastrointestinal oncology; Glycoprotein; Metastasis; MUC1; Mucin; Tumorigenicity

Indexed keywords

BETA CATENIN; LEUKOCYTE ENHANCING FACTOR 1; MUCIN 1; TRANSCRIPTION FACTOR; UVOMORULIN; CA 15-3 ANTIGEN; CADHERIN; LIGAND;

CANCER INVASION; CELL INTERACTION; COLON CARCINOGENESIS; COLORECTAL CANCER; COMPLEX FORMATION; EDITORIAL; EVIDENCE BASED MEDICINE; GENE EXPRESSION REGULATION; HUMAN; MITOSIS INHIBITION; PATHOPHYSIOLOGY; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL PROLIFERATION; COLORECTAL TUMOR; CYTOPLASM; GASTROENTEROLOGY; GASTROINTESTINAL TUMOR; METABOLISM; METASTASIS; METHODOLOGY; ONCOLOGY; PATHOLOGY; PHOSPHORYLATION; REVIEW;

BETA CATENIN; CA-15-3 ANTIGEN; CADHERINS; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CYTOPLASM; GASTROENTEROLOGY; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIGANDS; MEDICAL ONCOLOGY; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; PHOSPHORYLATION;

EID: 49249087639     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.2139     Document Type: Editorial

References (21)

1. Patton S, Gendler SJ, Spicer AP. The epithelial mucin, MUC1, of milk, mammary gland and other tissues. Biochim Biophys Acta 1995; 1241: 407-423
2. Muller S, Alving K, Peter-Katalinic J, Zachara N, Gooley AA, Hanisch FG. High density O-glycosylation on tandem repeat pepticle from secretory MUC1 of T47D breast cancer cells. J Biol Chem 1999; 274: 18165-18172
3. McAuley JL, Linden SK, Png CW, King RM, Pennington HL, Gendler SJ, Florin TH, Hill GR, Korolik V, McGuckin MA. MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest 2007; 117: 2313-2324
4. Merlo GR, Siddiqui J, Cropp CS, Liscia DS, Lidereau R, Callahan R, Kufe DW. Frequent alteration of the DF3 tumor-associated antigen gene in primary human breast carcinomas. Cancer Res 1989; 49: 6966-6971
5. Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 2004; 23: 77-99
6. Yin L, Kharbanda S, Kufe D. Mucin 1 oncoprotein blocks hypoxia-inducible factor 1alpha, activation in a survival response to hypoxia. J Biol Chem 2007; 282: 257-266
7. Carraway KL 3rd, Funes M, Workman HC, Sweeney C. Contribution of membrane mucins to tumor progression through modulation of cellular growth signaling pathways. Curr Top Dev Biol 2007; 78: 1-22
8. Niv Y, Schwartz B, Amsalem Y, Lamprecht SA. Human HT-29 colon carcinoma cells: mucin production and tumorigenicity in relation to growth phases. Anticancer Res 1995; 15: 2023-2027
9. Duncan TJ, Watson NF, Al-Attar AH, Scholefield JH, Durrant LG. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer. World J Surg Oncol 2007; 5: 31
10. Bresalier RS, Niv Y, Byrd JC, Duh QY, Toribara NW, Rockwell RW, Dahiya R, Kim YS. Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J Clin Invest 1991; 87: 1037-1045
11. Kaneko I, Tanaka S, Oka S, Yoshida S, Hiyama T, Arihiro K, Shimamoto F, Chayama, K. Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer. World J Gastroenterol 2007; 13: 3829-3835
12. Lugli A, Zlobec I, Baker K, Minoo P, Tornillo L, Terracciano L, Jass JR. Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status. J Clin Pathol 2007; 60: 534-539
13. Mukherjee P, Pathangey LB, Bradley JB, Tinder TL, Basu GD, Akporiaye ET, Gendler SJ. MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model. Vaccine 2007; 25: 1607-1618
14. Lillehoj EP, Lu W, Kiser T, Goldblunt SE, Kim KC. MUC1 inhibits cell proliferation by a beta-catenin-dependent mechanism. Biochim Biophys Acta 2007; 1773: 1028-1038
15. Yuan Z, Wong S, Borrelli A, Chung MA. Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation. Biochem Biophys Res Commun 2007; 362: 740-746
16. Li Y, Kuwahara H, Ren J, Wen G, Kufe D. The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin. J Biol Chem 2001; 276: 6061-6064
17. Huang L, Chen D, Liu D, Yin L, Kharbanda S, Kufe D. MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin. Cancer Res 2005; 65: 10413-10422
18. Baldus SE, Monig SP, Huxel S, Lanclsberg S, Hanisch FG, Engelmann K, Schneider PM, Thiele J, Holscher AH, Dienes HP. MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res 2004; 10: 2790-2796
19. Huang L, Ren J, Chen D, Li Y, Kharbanda S, Kufe D. MUC1 cytoplasmic domain coactivates Wnt target gene transcription and confers transformation. Cancer Biol Ther 2003; 2: 702-706
20. Li Y, Bharti A, Chen D, Gong J, Kufe D. Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin. Mol Cell Biol 1998; 18: 7216-7224
21. Shin SK, Nagasaka T, Jung BH, Matsubara N, Kim WH, Carethers JM, Boland CR, Goel A. Epigenetic and genetic alterations in Netrin-1 receptors UNC5C and DCC in human colon cancer. Gastroenterology 2007; 133: 1849-1857